Melatonin for Sleep: What It May Help and What Remains Unclear

Melatonin is a hormone involved in the body's sleep-wake timing. Prescription and over-the-counter products are not interchangeable, and a supplement should not be assumed to be a universal insomnia treatment. The evidence differs by sleep problem, age, product, and timing.

Possible uses are specific

NCCIH distinguishes evidence for different sleep problems, including jet lag and shift-related sleep difficulty; study findings vary and should not be treated as a general promise of benefit. Some studies suggest benefits for how quickly people with insomnia fall asleep, but results do not show improvement in every aspect of insomnia. Clinical practice guidelines have recommended against melatonin for chronic insomnia because evidence is not strong enough to support routine use. Persistent sleep difficulty deserves evaluation for contributing factors and evidence-based treatment options.

Safety needs attention

Short-term use appears relatively safe for many adults, but the long-term safety of supplements is not established. Reported short-term side effects can include headache, dizziness, nausea, and sleepiness. Melatonin can interact with medicines; people taking blood thinners or living with epilepsy should use it only with medical supervision. Pregnancy, breastfeeding, older age, and giving a supplement to a child call for professional advice.

Product labels can be unreliable

In the United States, melatonin is sold as a dietary supplement, under rules different from those for medicines. Studies have found that some products do not contain the amount listed on the label. Gummies can pose an accidental-ingestion risk to children, so store all supplements securely and use child-resistant packaging where available.

Before trying melatonin, identify the sleep problem and review medicines and health conditions with a clinician or pharmacist. Do not use it to mask severe daytime sleepiness, breathing problems during sleep, or a persistent change in sleep without evaluation.

What the journal evidence adds

The 2017 AASM medication guideline suggests against using melatonin for chronic insomnia in adults on the evidence it reviewed. This is a limited clinical recommendation about a particular problem; it is not proof that melatonin has no role in every timing-related condition.

The first question is therefore what sleep difficulty is being addressed. Ask a clinician whether evaluation or a structured treatment is more appropriate than trying a product marketed for sleep. Claims about a different population, formulation, or outcome may not apply. This article does not recommend a dose, product, or timing schedule. A supplement's availability without a prescription does not remove the need to consider interactions, accidental ingestion, and uncertainty about long-term use. Bring the actual product label if discussing it with a pharmacist.

Sources and further reading

• Sleep Disorders and Complementary Health Approaches - National Center for Complementary and Integrative Health. NIH evidence summary.
• Melatonin: What You Need To Know - NCCIH. NIH evidence summary.
• Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline - Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine (2017). clinical guideline.

Health disclaimer

This article is for general education only. Its information and suggestions are not medical advice, diagnosis, or treatment and may not be right for everyone. Ask a qualified health professional for advice that fits your health, medications, and needs before changing your diet, exercise, supplement use, or care.